1-6 of 6
Rik Schots, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Survival and Quality of Life Analysis after Autologous Stem Cell Transplantation for Lymphoma

Sylvia Faict, MD, Nathan De Beule, MD, Ann De Becker, MD, Karel Fostier, MD, Fabienne Trullemans, MD, Henri (Rik) Schots, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2268.
https://doi.org/10.1182/blood.V128.22.2268.2268
Published: 2016
Journal Articles

Immunomodulatory Drugs Restore Effector Cell Immune Functions In Myeloma Patients With Low Disease Burden After Autologous Stem Cell Transplantation

Karel Fostier, MD, Jurgen Corthals, Carlo Heirman, Joeri L. Aerts, PhD, Kris Thielemans, MD, PhD, Rik Schots, MD, PhD, Brenda De Keersmaecker, PhD
Journal: Blood
Blood (2013) 122 (21): 3214.
https://doi.org/10.1182/blood.V122.21.3214.3214
Published: 2013
Journal Articles

Outcomes Of Allogeneic Cord Blood Transplantation For Leukodystrophies; A Joint Study of Eurocord and “Inborn Errors WP-EBMT”

Hol Janna, Annalisa Ruggeri, MD, Vanderson Rocha, MD, Gerard Michel, Mouhab Ayas, MD, Tracey O'Brien, Gergely Krivan, Bordon Victoria, Rik Schots, MD, PhD, Rovelli Attilio, Elorza Izaskun, Jose M Moraleda, Peter J. Shaw, MBBS, MA, Marleen Renard, Karl-Walter Sykora, MD, Reuven Or, MD, Tsila Zuckerman, MD, Manuel Abecasis, Bredius Robbert, M. Akif Yesilipek, Miguel Angel Diaz, MD, PhD, Gennery Andy, Eliane Gluckman, MD, Jaap Jan Boelens, MD PhD
Journal: Blood
Blood (2013) 122 (21): 2101.
https://doi.org/10.1182/blood.V122.21.2101.2101
Published: 2013
Journal Articles

Dll1/Notch Interaction Contributes to a Decreased Sensitivity of Myeloma Cells to Bortezomib

Dehui Xu, Jingsong Hu, Elke De Bruyne, PhD, Eline Menu, PhD, Rik Schots, MD, Karin Vanderkerken, PhD, Els Van Valckenborgh, PhD
Journal: Blood
Blood (2012) 120 (21): 1840.
https://doi.org/10.1182/blood.V120.21.1840.1840
Published: 2012
Journal Articles

Rituximab Purging and Maintenance Improves Progression Free Survival but Not Overall Survival In Patients with Relapsed or Resistant Follicular Lymphoma Prior Receiving An Autologous Transplant

Ruth Pettengell, MD, Norbert Schmitz, MD, Christian Gisselbrecht, MD, Graeme Smith, MD, William N Patton, MD, Bernd Metzner, MD, Dolores Caballero, MD, Herve Tilly, MD, Jan A Walewski, MD, Isabelle Bence-Bruckler, MD, Bik To, MD, Christian H. Geisler, MD, Rik Schots, MD, Eva Kimby, MD, Christian J. Taverna, MD, T. Kozak, MD, Ruzena Uddin, MSci, Carmen Ruiz de Elvira, PhD, Anthony H. Goldstone, MD
Journal: Blood
Blood (2010) 116 (21): 3567.
https://doi.org/10.1182/blood.V116.21.3567.3567
Published: 2010
Journal Articles

Darbepoetin-Alfa and I.V. Iron Administration after Autologous Hematopoietic Stem Cell Transplantation: A Prospective Randomized Multicenter Trial

Yves Beguin, Johan Maertens, Bernard De Prijck, Rik Schots, MD, Pascale Frere, Christophe Bonnet, Kaoutar Hafraoui, Evelyne Willems, Gaetan Vanstraelen, Marie Lejeune, Koen Theunissen, Georges Fillet, Frederic Baron
Journal: Blood
Blood (2008) 112 (11): 54.
https://doi.org/10.1182/blood.V112.11.54.54
Published: 2008